IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q3 2025 Holdings

Filed 2025-11-10 | 3 holdings | $3.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Werewolf Therapeutics Inc(HOWL)COM95075A107$1.2M589,10237.3%
Tscan Therapeutics Inc(TCRX)COM89854M101$1.1M630,00036.9%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$802.8K642,20425.8%